Please do not include any intro or closing. Company Performance: Revenue growth, profitability, and pipeline progress in developing biosimilar and generic drugs influence investor confidence.

Regulatory Approvals: Positive decisions from regulatory bodies like the FDA for new products significantly impact stock price.

Market Competition: The presence of competitors and pricing pressures in the biosimilar and generic drug market affect revenue and market share.

Patent Litigation: Legal battles over patents for existing drugs can create uncertainty and affect future profitability.

Economic Conditions: Broader economic factors like inflation and interest rates can influence investment decisions and overall market sentiment towards pharmaceutical stocks.

Industry Trends: Shifts in healthcare policies, such as reimbursement rates for biosimilars, can impact the company's financial outlook.

Investor Sentiment: General investor perception and market trends can lead to fluctuations in stock price, sometimes unrelated to the company's fundamentals.

Management Team: The experience and strategic decisions of the management team impact investor confidence and the company's long-term prospects.